Mayfield Medical Properties Ltd - Accounts to registrar (filleted) - small 18.2

Mayfield Medical Properties Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.3.0.228 04413846 Board of Directors 1.1.19 31.12.19 31.12.19 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure044138462018-12-31044138462019-12-31044138462019-01-012019-12-31044138462018-04-30044138462018-05-012018-12-31044138462018-12-3104413846ns16:EnglandWales2019-01-012019-12-3104413846ns15:PoundSterling2019-01-012019-12-3104413846ns11:Director12019-01-012019-12-3104413846ns11:PrivateLimitedCompanyLtd2019-01-012019-12-3104413846ns11:SmallEntities2019-01-012019-12-3104413846ns11:AuditExempt-NoAccountantsReport2019-01-012019-12-3104413846ns11:SmallCompaniesRegimeForDirectorsReport2019-01-012019-12-3104413846ns11:SmallCompaniesRegimeForAccounts2019-01-012019-12-3104413846ns11:FullAccounts2019-01-012019-12-310441384612019-01-012019-12-3104413846ns11:Director22019-01-012019-12-3104413846ns11:Director32019-01-012019-12-3104413846ns11:Director42019-01-012019-12-3104413846ns11:RegisteredOffice2019-01-012019-12-3104413846ns6:CurrentFinancialInstruments2019-12-3104413846ns6:CurrentFinancialInstruments2018-12-3104413846ns6:Non-currentFinancialInstruments2019-12-3104413846ns6:Non-currentFinancialInstruments2018-12-3104413846ns6:ShareCapital2019-12-3104413846ns6:ShareCapital2018-12-3104413846ns6:RevaluationReserve2019-12-3104413846ns6:RevaluationReserve2018-12-3104413846ns6:RetainedEarningsAccumulatedLosses2019-12-3104413846ns6:RetainedEarningsAccumulatedLosses2018-12-3104413846ns6:LandBuildings2018-12-3104413846ns6:FurnitureFittings2018-12-3104413846ns6:LandBuildings2019-01-012019-12-3104413846ns6:FurnitureFittings2019-01-012019-12-3104413846ns6:LandBuildings2019-12-3104413846ns6:FurnitureFittings2019-12-3104413846ns6:LandBuildings2018-12-3104413846ns6:FurnitureFittings2018-12-3104413846ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-12-3104413846ns6:CurrentFinancialInstrumentsns6:WithinOneYear2018-12-3104413846ns6:Secured2019-12-3104413846ns6:Secured2018-12-3104413846ns6:DeferredTaxation2018-12-3104413846ns6:DeferredTaxation2019-12-31
REGISTERED NUMBER: 04413846 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2019

FOR

MAYFIELD MEDICAL PROPERTIES LTD

PREVIOUSLY KNOWN AS
PREMIER MEDICAL PROPERTIES LTD

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MAYFIELD MEDICAL PROPERTIES LTD

COMPANY INFORMATION
for the year ended 31 December 2019







DIRECTORS: P K Krishan
K S Krishan
S S Krishan
S S Krishan





REGISTERED OFFICE: 7 Bell Yard
London
WC2A 2JR





REGISTERED NUMBER: 04413846 (England and Wales)





ACCOUNTANTS: Magma Audit LLP
Magma House
16 Davy Court
Castle Mound Way
Rugby
CV23 0UZ

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

BALANCE SHEET
31 December 2019

2019 2018
Notes £    £   
FIXED ASSETS
Tangible assets 4 2,336,535 2,342,821

CURRENT ASSETS
Debtors 5 123,663 130,329
Cash at bank 3,174 17,582
126,837 147,911
CREDITORS
Amounts falling due within one year 6 (346,381 ) (338,050 )
NET CURRENT LIABILITIES (219,544 ) (190,139 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,116,991

2,152,682

CREDITORS
Amounts falling due after more than one year 7 (735,000 ) (840,000 )

PROVISIONS FOR LIABILITIES 9 (133,611 ) (133,611 )
NET ASSETS 1,248,380 1,179,071

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

BALANCE SHEET - continued
31 December 2019

2019 2018
Notes £    £   

CAPITAL AND RESERVES
Called up share capital 100 100
Revaluation reserve 550,896 550,896
Retained earnings 697,384 628,075
1,248,380 1,179,071

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 December 2020 and were signed on its behalf by:





S S Krishan - Director


MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2019


1. STATUTORY INFORMATION

Mayfield Medical Properties Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
-the amount of revenue can be measured reliably;
-it is probable that the Company will receive the consideration due under the contract;
-the stage of completion of the contract at the end of the reporting period can be measured reliably; and
-the costs incurred and the costs to complete the contract can be measured reliably.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical costs includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using either a straight line or reducing balance method, as indicated below.

Depreciation is provided on the following basis:

Fixtures and fittings - 20%straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are
recognised in profit or loss.

Freehold land & buildings
Land and buildings are initially recognised at cost which includes purchase cost and any directly attributable expenditure.

Land and buildings whose fair value can be measured reliably are measured at fair value. The surplus or deficit on revaluation is recognised in the profit and loss account accumulated in an other reserve unless a deficit below original cost, or its reversal, on an individual land or building is expected to be permanent, in which case it is recognised in the profit and loss account for the year.

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2019


2. ACCOUNTING POLICIES - continued

Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

Taxation
The tax expense for the year comprises current and deferred tax.

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2018 - 2 ) .

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2019


4. TANGIBLE FIXED ASSETS
Freehold Fixtures
land & and
buildings fittings Totals
£    £    £   
COST OR VALUATION
At 1 January 2019
and 31 December 2019 2,335,000 37,942 2,372,942
DEPRECIATION
At 1 January 2019 - 30,121 30,121
Charge for year - 6,286 6,286
At 31 December 2019 - 36,407 36,407
NET BOOK VALUE
At 31 December 2019 2,335,000 1,535 2,336,535
At 31 December 2018 2,335,000 7,821 2,342,821

Cost or valuation at 31 December 2019 is represented by:

Freehold Fixtures
land & and
buildings fittings Totals
£    £    £   
Valuation in 2007 612,329 - 612,329
Valuation in 2018 67,790 - 67,790
Cost 1,654,881 37,942 1,692,823
2,335,000 37,942 2,372,942

The directors have assessed the market value of the company's property and do not consider it to be materially different to the carrying value.

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors - 15,252
Amounts owed by participating interests 122,097 112,494
Other debtors 1,566 2,583
123,663 130,329

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Bank loans and overdrafts 105,000 105,000
Trade creditors 15,677 2,940
Amounts owed to participating interests 69,322 103,370
Taxation and social security 65,803 71,675
Other creditors 90,579 55,065
346,381 338,050

MAYFIELD MEDICAL PROPERTIES LTD (REGISTERED NUMBER: 04413846)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2019


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2019 2018
£    £   
Bank loans 735,000 840,000

8. SECURED DEBTS

The following secured debts are included within creditors:

2019 2018
£    £   
Bank loans 840,000 945,000

The bank loan is covered by both a fixed and floating charge with Handelsbanken PLC. The floating charge covers all the property or undertaking of the company.

9. PROVISIONS FOR LIABILITIES
2019 2018
£    £   
Deferred tax 133,611 133,611

Deferred
tax
£   
Balance at 1 January 2019 133,611
Balance at 31 December 2019 133,611

10. RELATED PARTY DISCLOSURES

At the period end, a balance of £69,322 (2018: £103,370) was owed to a company with common directorships. Sales of £31,832 (2018: £21,555) were made to this company during the period.

At the period end, a balance of £122,097 (2018: £112,494) was owed by a partnership in which the directors are partners. Sales of £94,300 (2018: £62,867) were made to partnership during the period.